Virologist Connor Bamford and Professor John McLauchlan, both of the University of Glasgow, explain to the Hepatitis SA Community News how their research shows that not all people are equally vulnerable to hepatitis C.
The hepatitis C virus (HCV) infects around 1per cent of the human population and is a devastating pathogen. In most people, it silently infects the liver for decades, and can cause life-threatening inflammation, scarring and even cancer. How the virus achieves this feat has long puzzled scientists.
Continue reading “Why are a small group of people born immune to hepatitis C?”
New national guidelines endorsed by the Australian Health Ministers’ Advisory Council have been released in January 2019 for healthcare workers who perform exposure-prone procedures, and for healthcare workers living with a blood-borne virus (BBV).
These are the Australian National Guidelines for the Management of Healthcare Workers Living with Blood Borne Viruses and Healthcare Workers who Perform Exposure Prone Procedures at Risk of Exposure to Blood Borne Viruses.
Continue reading “New guidelines mean more freedom for healthcare workers living with BBVs”
Even in a country like Australia, with a high standard of living and a socialised health system, the battle to eliminate hepatitis can be challenging. So what is it like in a country like India, where poverty, population pressures and lack of health funding and education make every medical challenge so much harder?
Dr Sunil Solomon is Associate Professor of Medicine at the prestigious Johns Hopkins University School of Medicine. He spoke at the Australasian Viral Hepatitis Conference in Adelaide about his work on eliminating HCV among people in India who inject drugs.
Continue reading “Treating Hepatitis C Under Nearly Impossible Conditions”